Categories

78 pages

Exclusive Analysis

Druckenmiller vs. Bessent on Treasury Buybacks: Credibility Matters More Than $4 Billion

NVIDIA's Earnings Changed the Question: Watch Memory Bottlenecks and Supplier Financing, Not Just Peak AI Capex

Good Companies and Cheap Stocks Are Different Lists: Anatomy of Fourteen Korean Valuations

A Map of Biotech Investing: Where You Earn Only If the Drug Works, and Where You Earn Whichever Drug Works

Anatomy of the Rebound: Foreign Buying Came in Two Bursts, and the Same Two Stocks Changed Hands

AI's Bottleneck Really Is HBM, Not the GPU: But Bottlenecks Invite Workarounds

The Second Week of August in Review: AI Capital Moves to Wall Street, and Good News Starts Lasting Two Days

A Rebound Won't Come From a Single Trigger: A Verdict Calendar From Late August to Year-End

What Hyperscaler Earnings Proved, and What They Didn't: Three Explanations for the Memory Sell-Off

The U.S.-Japan Yen Intervention and FIMA: Did Lower Oil Unlock the August Macro Regime?